Melanoma Clinical Trials
Find clinical trials for melanoma. Search for melanoma clinical trials in different cities and states across the United States.
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefStereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
Sponsor:
Hamilton Health Sciences Corporation
Location:
Code:
NCT04177056
Conditions
Bone Metastases
Prostate Cancer
Breast Cancer
Renal Cell Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SBRT
BMS-986340, Nivolumab, DocetaxelA Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT04895709
Conditions
Cervical Cancer
Gastric/Gastroesophageal Junction Adenocarcinoma
Microsatellite Stable Colorectal Cancer
Non-Small-Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986340
BMS-936558-01
Docetaxel
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaLymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT03941756
Conditions
Anatomic Stage III Breast Cancer AJCC v8
Breast Inflammatory Carcinoma
Locally Advanced Breast Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Indocyanine Green
Lymphangiography
Lymphovenous Bypass
Observational StudyStorage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Sponsor:
Vanderbilt-Ingram Cancer Center
Location:
Code:
NCT01205815
Conditions
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tissue and blood collection
Interested in new trials?
Get alerts for new trials in your area by subscribing now
VET3-TGIA Study of VET3-TGI in Patients With Solid Tumors
Sponsor:
KaliVir Immunotherapeutics
Location:
Code:
NCT06444815
Conditions
Solid Tumor, Adult
Microsatellite Stable Colorectal Cancer
Head and Neck Squamous Cell Carcinoma
Cervical Cancer
Kidney Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
VET3-TGI
Pembrolizumab
Observational StudyCirculating Tumor DNA Exposure in Peripheral Blood
Sponsor:
Quantgene Inc.
Location:
Code:
NCT03517332
Conditions
Colorectal Cancer
Pancreatic Adenocarcinoma
Gastric Cancer
Hepatocellular Carcinoma
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Immune RecallA Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Sponsor:
Duke University
Location:
Code:
NCT05077137
Conditions
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tetanus Diptheria Vaccine
Polio Boost Immunization
PD-1/PD-L1 InhibitorEvaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
Sponsor:
Jason J. Luke, MD
Location:
Code:
NCT04157985
Conditions
Advanced Solid Tumors
NSCLC
Bladder Cancer
HNSCC
Renal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Continue PD-1/PD-L1 Inhibitors treatment
Discontinue PD-1/PD-L1-1 inhibitor
Anti-PD1 & CombinationsNeoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Location:
Code:
NCT06295159
Conditions
Melanoma Stage III
Melanoma Stage IV
Advanced Melanoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Nivolumab + Relatlimab
Ipilimumab